Patel Chem Specialities Ltd (PATELCHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Patel Chem Specialities Ltd on NSE and BSE, with an AI summary of each filing.
Imposition of Fine by BSE u/r 34
Others (Uncategorized) · 02 Nov 2026, 3:58 pm
Patel Chem Specialities Receives BSE Fine for Alleged Regulation 34 Non-Compliance Patel Chem Specialities received a communication dated 30th Oct'26 from BSE Limited levying a fine of ₹1,22,720 for alleged non-compliance with Regulation 34 regarding the filing of its FY26 Annual Report. The company clarified that the report was submitted within prescribed timelines, attributing the issue to an inadvertent error in selecting the financial year parameter during upload. Management confirmed zero impact on financial position or business operations and is submitting a clarification to BSE seeking a full waiver or reconsideration of the fine.
Annual Report for the F. Y 2025-26.
Others (Uncategorized) · 31 Oct 2026, 5:39 pm
Cancellation of Investor Meeting
Intimation · 22 Oct 2026, 10:14 pm
Patel Chem Specialities Cancels Scheduled Analyst and Institutional Investor Meetings Patel Chem Specialities Limited has announced the cancellation of its analyst and institutional investor meetings previously scheduled for 26th Oct'26. According to the company's regulatory filing with the BSE under Regulation 30(6) of SEBI LODR Regulations, 2015, the scheduled interactions were called off due to unforeseen business exigencies.
Patel Chem Specialities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Patel Chem Specialities ....
Intimation · 05 Nov 2026, 5:30 am
Patel Chem Specialities Schedules Board Meeting for Half-Year Financial Results Patel Chem Specialities Limited has scheduled a meeting of its Board of Directors on 5th Nov'26 to consider, approve, and take on record the unaudited financial results along with the Auditor’s Limited Review Report for the half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities was closed on 1st Oct'26 and will remain shut until 48 hours post-declaration, reopening on 7th Nov'26.
Intimation for the investor meet to be held on 26th October, 2026
Intimation · 22 Oct 2026, 4:36 pm
Patel Chem Specialities Schedules Investor Meet with Phillip Capital Patel Chem Specialities Limited announced that its Key Managerial Personnel will participate in an Investor Meet via video conference with Phillip Capital on 26th Oct'26. The interaction aims to discuss and clarify publicly available industry and company information, with no unpublished price-sensitive information (UPSI) scheduled for discussion.
Commencement of the trial batches at Talod Plant.
Press Release · 07 Oct 2026, 4:41 pm
Patel Chem Specialities Completes Talod Facility Expansion, Scaling Capacity to 4,500 MTPA Patel Chem Specialities completed the expansion of its Talod, Gujarat manufacturing plant, scaling annual production capacity ~6.25× from 720 MTPA to 4,500 MTPA. The ~₹20 crore capex project was funded via bank loans and internal accruals. Trial batches have commenced, with commercial production slated to start shortly. At peak utilization, the Talod facility has the potential to generate annual revenue of ₹85–100 crore, addressing rising demand for cellulose-based excipients and speciality chemicals while shortening delivery schedules.
Commercial Production from the Expanded Facility to Commence Shortly.
Others (Uncategorized) · 06 Oct 2026, 7:05 pm
Patel Chem Specialities Completes Talod Plant Expansion to 4,500 MTPA Patel Chem Specialities Limited has completed the expansion of its Talod plant, scaling manufacturing capacity from 720/750 MTPA to 4,500 MTPA to address growing market demand and shorten delivery cycles. Trial batches have commenced, with commercial production expected to begin shortly. The project entailed a capex of approximately ₹20 Cr, funded via bank borrowings and internal accruals. The enhanced facility will support long-term business growth following optimal utilization of its prior capacity.
Outcome of Investor Conference
Others (Uncategorized) · 30 Sept 2026, 10:22 pm
Patel Chem Specialities Concludes Participation in Arihant Investor Conference Patel Chem Specialities Limited participated in the virtual Arihant Bharat Connect Conference: Rising Stars 2026, hosted by Arihant Capital, on 30th Sep'26 from 03:00 PM to 04:00 PM. Company management engaged in interactions with investors and analysts during the session. The company confirmed that no Unpublished Price Sensitive Information (UPSI) was shared during the event.
Acquisition of Share by the Promoter Group.
Others (Uncategorized) · 28 Sept 2026, 9:50 pm
Patel Chem Specialities Promoter Group Acquires Additional Equity Shares Patel Chem Specialities Limited announced that promoter group member Devansh Bhupesh Patel acquired 1,200 equity shares of the company on 25th Sep'26. The transaction was executed via an off-market transfer from seller Tulsi Chauhan. The disclosure was submitted to the exchange on 28th Sep'26 pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
Voting Result along with Scrutinizer Report for the 18th AGM , 2026
Annual General Meeting · 26 Sept 2026, 10:48 pm
Outcome of the 18th AGM , 2026 held on 25th September, 2026 at 11:00 A.M
Annual General Meeting · 25 Sept 2026, 5:15 pm
Bharat Connect Conference - Rising Stars is schedule on 30th September 2026
Intimation · 22 Sept 2026, 10:43 pm
Patel Chem Specialities to Attend Arihant Bharat Connect Conference Rising Star Patel Chem Specialities Limited announced that its management will participate in the virtual 'Arihant Bharat Connect Conference Rising Star', organized by Arihant Capital, scheduled for 30th Sep'26. The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the event.
Record date for the 18th AGM
Annual General Meeting · 15 Sept 2026, 10:11 pm
Annual Report for the Financial Year 2025-26
Others (Uncategorized) · 01 Sept 2026, 5:50 pm
18th AGM Notice
Annual General Meeting · 01 Sept 2026, 5:46 pm
1. Recommended the Re-appointment of Mrs. Anshu Bhupesh Patel (DIN: 02148403), who retires by rotation offers herself for re-appointment as a Director. 2. Received, considered and approved ....
Outcome · 01 Sept 2026, 5:39 pm
Patel Chem Specialities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve 1. To consider re-appointment ....
Intimation · 26 Aug 2026, 9:32 pm
Clarification regarding observation on Deviation in Utilization of IPO proceed as Reported by the Monitoring Agency.
Others (Uncategorized) · 14 Aug 2026, 9:19 pm
Patel Chem Clarifies Minor Deviation in IPO Proceeds Utilization On 14-Aug'26, Patel Chem clarified that a reported ₹0.015 crore deviation in IPO proceeds for Q1 FY27 was not a diversion of funds. The shortfall resulted from a penalty deducted by Axis Bank for the premature closure of a fixed deposit, which held the IPO funds. The company stated this amount was not used for any other purpose and confirmed its commitment to replenish the shortfall and utilize the proceeds as originally stated in the Red Herring Prospectus (RHP).
Monitoring Agency Report for June Quarter, 2026
Others (Uncategorized) · 14 Aug 2026, 9:13 pm
Patel Chem: Monitoring Agency Report on IPO Proceeds for Q1FY27 For the quarter ended 30 Jun'26, Patel Chem utilized Rs 1.45 crore of IPO proceeds towards capex, leaving an unutilized balance of Rs 34.79 crore. A minor shortfall of Rs 0.015 crore exists in the monitoring account due to a penalty on premature FD closure. Management has committed to covering this shortfall in Q2FY27. The total capex cost for the Indrad plant has been revised to Rs 45.00 crore from the initial Rs 43.15 crore, with no project delays reported.
Statement of Deviation and Variation for the Half Year Ended 31st March, 2026.
Others (Uncategorized) · 28 May 2026, 3:56 pm
Patel Chem Confirms No Deviation in Use of IPO Proceeds Patel Chem Specialities confirmed no deviation in utilizing its ₹58.80 crore IPO proceeds for the half-year ended 31 Mar'26. Of the total, ₹22.56 crore has been utilized, leaving an unutilized balance of ₹36.24 crore. Key unspent amounts include ₹35.89 crore for Capex, held in a fixed deposit, and ₹0.35 crore for issue-related expenses, held in a current account. The Board and Audit Committee reviewed the utilization statement on 21 May'26, verifying compliance with the prospectus objectives.
Appointment of the Secretarial Auditor for the Financial Year 2026-27.
Change in Management · 22 May 2026, 7:30 pm
Patel Chem Re-appoints Secretarial Auditor for FY 2026-27 Patel Chem Specialities Limited's Board of Directors has approved the re-appointment of M/s RTBR & ASSOCIATES as the company's Secretarial Auditor for the financial year 2026-27. This decision, based on the Audit Committee's recommendation, was made during the board meeting held on 22 May'26. The re-appointment ensures compliance with SEBI Listing Regulations and the Companies Act, 2013. M/s RTBR & ASSOCIATES is noted as a firm with extensive experience in secretarial audits. No relationships between directors were disclosed.
Appointment of the Internal Auditor for the Financial Year 2026-27.
Change in Management · 22 May 2026, 7:29 pm
Patel Chem Re-Appoints Bimal Shah Associates as Internal Auditor for FY27 Patel Chem Specialities Limited announced its Board of Directors, on the Audit Committee's recommendation, re-appointed M/s Bimal Shah Associates as its Internal Auditor. The appointment is effective from 22 May'26 for the financial year 2026-27. This decision aligns with the Companies Act, 2013, and SEBI listing regulations. The reappointment indicates continuity in the company's internal financial controls and audit processes, with Bimal Shah Associates noted for its extensive experience in the field.
Appointment of the Cost Auditor for the Financial Year 2026-27.
Change in Management · 22 May 2026, 7:27 pm
Patel Chem Appoints M/s BRS & Associates as Cost Auditor for FY27 Patel Chem Specialities Limited (BSE: 544460) announced its Board of Directors approved the appointment of M/s BRS & Associates (FRN-000730) as Cost Auditor for the financial year 2026-27. The appointment, recommended by the Audit Committee, was made effective from 22 May'26. This action is to comply with the Companies Act, 2013 and SEBI Listing Regulations. M/s BRS & Associates is a firm with extensive experience in cost audit, compliance, and management advisory services.
Audited Financial Result for Half-Year and Year Ended 31st March, 2026.
Financial Result · 22 May 2026, 7:21 pm
Patel Chem FY26 Results: Strong Top-Line and Profit Growth Patel Chem Specialities reported robust FY26 results with revenue from operations growing 30.6% YoY to ₹13,726.33 lakhs. Net profit increased by 18.8% YoY to ₹1,255.22 lakhs from ₹1,056.52 lakhs in FY25. The company's basic EPS for FY26 stood at ₹6.63. Total assets grew significantly to ₹14,227.90 lakhs from ₹6,531.32 lakhs YoY, primarily driven by an increase in share capital post-IPO and growth in reserves. The Board approved the audited financials for the year ended 31 Mar'26.
Outcome of Board Meeting for the Half Year and Year Ended on 31st March,2026.
Outcome · 22 May 2026, 7:03 pm
Patel Chem Specialities Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 7,611 (+38.5% YoY | +24.4% QoQ) ■ EBITDA: 868 (+14.0% YoY | +3.4% QoQ) ■ EBITDA Margin (%): 11.4 (-245 bps YoY | -232 bps QoQ) ■ PAT: 642 (+20.3% YoY | +4.8% QoQ) ■ EPS (INR): 3.39 (-19.3% YoY | +11.9% QoQ)